worldwide offices | stay connected | contact | help | sitemap

 
 

 

 

 

Novartis Products

Novartis Products

Pharmaceuticals

Our global Pharmaceuticals portfolio includes more than 50 key marketed products, many of which are leaders in their respective therapeutic areas. In 2008 we achieved 11 successful market launches in the United States and the European Union.

Key pharmaceutical products marketed by Novartis are listed below by therapeutic area.

Click on the product link where available to display complete product information. Please note that some product links are intended for US residents only.

A-Z

A C D E F G L M N P R S T V X Z

 

 

 

Famvir (famciclovir)

  • Acute herpes zoster including ophthalmic herpes zoster and decreased duration of post herpetic neuralgia
  • Acute treatment of 1st episode and recurrent genital herpes infections, and for the suppression of recurrent genital herpes
  • Treatment of recurrent herpes labialis (cold sores)
  • Indicated in immunocompromised patients with herpes zoster or herpes simplex infections

 

 

Femara (letrozole tablets/letrozole)

  • Advanced breast cancer in post-menopausal women (both as first and second-line therapies)
  • Early breast cancer in post-menopausal women following standard tamoxifen therapy (extended adjuvant therapy)
  • Early breast cancer in postmenopausal women following surgery (upfront adjuvant therapy)

 

 

Focalin & Focalin XR (dexmethylphenidate HCl & dexmethylphenidate modified release)

  • Attention deficit hyperactivity disorder

 

 

Foradil (formoterol)

  • Asthma
  • Chronic obstructive pulmonary disease

 

Back to top

Pharmaceuticals business at Novartis

Novartis discovers and develops innovative medicines with improved efficacy and fewer side-effects.

Latest news

Patient groups

Patient groups

Our commitment to high-quality healthcare has led to an enduring and trusted partnership between Novartis and various patient groups.